Achilles Tendinopathy Toolkit: Section A - Clinical Evaluation

Original Editor - User Name Top Contributors - Kim Jackson, Olajumoke Ogunleye, Cindy John-Chu and Rishika Babburu  
This article or area is currently under construction and may only be partially complete. Please come back soon to see the finished work! (18/05/2022)

Introduction[edit | edit source]

The purpose of this document is to summarize the clinical evaluation of somebody who has been diagnosed with Achilles Tendinopathy.

The first steps involved in assessing a person presenting with Achilles tendinopathy is to carry out a subjective and objective examination, including a detailed history, to confirm the diagnosis. The toolkit leads you through the process of identifying potential risk factors association with Mid-Portion Achilles Tendinopathy, important questions and observations that form part of the subjective and objective assessment, as well as discussing Functional Tests and Differential Diagnosis.

Risk Factors[edit | edit source]

There are potential risk factors associated with mid-portion achilles tendinopathy. These can be further classified as non-modifiable and modifiable risk factors:

  • Non-Modifiable Risk Factors
    • mid-age 30-60 years [ref 3,5]
    • male>female [ref 6]
    • Metabolic Disorders:
      • Renal disease [ref 3] - Urate deposits (tophi) in the Achilles tendon related to hyperuricemia (gout) [ref 7]
      • Diabetes [ref 3]
    • Family history:
      • Familial Hypercholesterolemia (HeFH) [ref 3] - New onset of Achilles tendon pain is often the first sign of hypercholesterolemia and should be investigated for serum cholesterol levels. [ref 7]. Tendon Xanthomas are fatty deposits from high cholesterol levels and commonly found at the Achilles tendon.
      • Genetic variants [ref 2,3] -Certain genetic polymorphisms predispose tendon to altered collagen structure.
    • Systemic Inflammatory Disorder:
      • Seronegative Spondyloarthropathy (SpA) - 98% of SpAhave at least one enthesis disorder, commonly at the Achilles tendon.[ref 9]. Consider use of SpAscreening tools such as SCREEND’EM [ref 9]
  • Modifiable Risk Factors
    • Lifestyle:
      • Smoking [ref 2,8]
      • Obesity [ref 3,7]
      • Alcohol (moderate consumption) [ref 2]
      • Sedentary behaviour, inactivity [ref 3]
    • Medications:
      • Fluoroquinolones [ref 2] - Specifically, Ofloxacin was identified compared to similar anti-biotics from the same drug group. [ref 1]
      • Systemic corticosteroid (long term Prednisone) [ref 10]
      • Hormone Replacement Therapy (HRT) [ref 5]
    • Previous lower extremity tendinopathy [ref 1]
    • Footwear [ref 2,4,5]
    • Biomechanics:
      • Limited dorsiflexion [ref 2,4,5]
      • Decreased plantar flexor strength [ref 2,4,5]
      • Limited hip mobility [ref 2]
      • Altered gait pattern [ref 2]
      • Foot posture and mechanics [ref 5] - Static exam: hindfoot INV/EV (subtalar mobility)[ref 5]
      • Dynamic exam: excess foot pronation [ref 2]
    • Training Errors:
      • Training load - abrupt change in load, intensity, or volume [ref 4]
      • Training environment - higher risk with cold weather and winter training season [ref 1]

Assessment[edit | edit source]

Things to look out for when assessing for achilles tendinopathy include; the subjective symptoms from patients, onset of injury, objective signs and psychological factors.

Clinical evaluation image 2.png
Clinical evaluation image 3.png

References[edit | edit source]